Named #1 firm for Global M&A
Recognized in Life Sciences and Healthcare
Recognized as a leader in patent law
Venture Capital Attorney of the Year
DA Litigation and Enforcement Firm of the Year
Awarded “Biotech Law Firm of the Year” for the seventh time
Recognized UK and US teams in Life Sciences & Pharmaceutical Sector (International
& Cross-Border)
Recognized in UK-wide Life Sciences: Transactional
Ranked Band 1 in Nationwide: Life Sciences
Ranked National Tier 1 in 23 areas
recognized Goodwin in the following areas for 2022:
Named Goodwin #1 firm for Global M&A in 2022
Goodwin’s UK and US teams in the Life Sciences & Pharmaceutical Sector (International & Cross-Border) category
Named Goodwin a leader in patent law
Venture Capital Attorney of the Year
Regulatory Attorney of the Year: FDA Pharmaceutical
FDA Litigation and Enforcement Firm of the Year
U.S. Life Cycle Firm of the Year for the 11th consecutive year, one of only eight firms to receive this distinction
Seven-time winner of Biotech Law Firm of the Year and National Tier 1 ranking in 23 areas
Goodwin in the
UK-wide Life Sciences: Transactional category
Ranked Goodwin Band 1 in the Nationwide: Life Sciences category
recognized Goodwin in the following areas for 2022:
Named “Licensing & Collaboration Firm of the Year”
Awarded “Impact Deal of the Year Award” for the second consecutive year
Named “FDA Litigation and Enforcement Firm of the Year”
Named “U.S. Life Cycle Firm of the Year” for the 12th consecutive year (one of only nine firms across the country to receive this distinction)
Named “Editor’s Choice Law Firm of the Year”
FDA Litigation and Enforcement Firm of the Year
Awarded “Biotech Law Firm of the Year” for the seventh time
Named Goodwin #1 firm for Global M&A in 2022